Ally Therapeutics, Inc. — Form D
Ally Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-09. The offering totals $11.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-08-09
- Form: D
- Accession: 0001785017-19-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $10.0M
- Remaining: $1.0M
- Investors: 3
- Date of first sale: 2019-07-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-346178
Issuer
- Name: Ally Therapeutics, Inc.
- CIK: 0001785017
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 325 VASSAR STREET, CAMBRIDGE, MA, 02139
- Phone: 617-526-6000
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Steve Gillis | Director | New York, NY |
| Tina Liu | Director | New York, NY |
| Bob More | Director | Venice, CA |
| Erica Whittaker | Director | South San Francisco, CA |
| David Cordo | Executive Officer | Cambridge, MA |
| Tina Liu | Executive Officer | New York, NY |
More